Bio-Rad Laboratories, Inc. (NYSE:BIO) acquired Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. (WSE:SCP) for approximately $170 million on August 3, 2022. The total consideration of $171 million, consisting of approximately $101 million in cash, and up to $70 million in future milestone payments payable upon achievement of certain technological development and sales-related milestones. Edward Grey, Crosby O'Hare, Peter Chudy, and Charles Jonscher of Clairfield International LLC acted as the financial advisor to Scope Fluidics.

Bio-Rad Laboratories, Inc. (NYSE:BIO) completed the acquisition of Curiosity Diagnostics Sp. z o.o. from Scope Fluidics S.A. (WSE:SCP) on August 3, 2022.